Nationwide Fund Advisors’s Fortress Biotech FBIO Stock Holding History

Nationwide Fund Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,196	Closed	-$79K	–	700
2017 Q3	$79K	Sell	1,196 -172	-13%	-$11.6K	﹤0.01%	2973
2017 Q2	$97K	Hold	1,368	–	–	﹤0.01%	2911
2017 Q1	$76K	Hold	1,368	–	–	﹤0.01%	2907
2016 Q4	$55K	Hold	1,368	–	–	﹤0.01%	2996
2016 Q3	$61K	Hold	1,368	–	–	﹤0.01%	3020
2016 Q2	$55K	Buy	+1,368	New	+$63.7K	﹤0.01%	3063
2014 Q2	–	Sell	-1,566	Closed	-$47K	–	3337
2014 Q1	$47K	Buy	1,566 +181	+13%	+$7.06K	﹤0.01%	2859
2013 Q4	$55K	Buy	1,385 +32	+2%	+$1.24K	﹤0.01%	3060
2013 Q3	$142K	Buy	1,353 +309	+30%	+$37.9K	﹤0.01%	2825
2013 Q2	$135K	Buy	+1,044	New	+$154K	﹤0.01%	2672

Other funds holding FBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

SIM

Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Nationwide Fund Advisors's FBIO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Fortress Biotech (FBIO) in Q4 2017, closing a stake of 1,196 shares — an estimated $79K sold.

Nationwide Fund Advisors first reported a position in FBIO in Q2 2013 and held it in 10 quarters. The position peaked at $142K in Q3 2013. 62 funds tracked by Wall St. Rank hold FBIO as of Q4 2017.

Nationwide Fund Advisors reported no remaining Fortress Biotech position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 1,196 Fortress Biotech shares in Q4 2017, an estimated $79K.
Nationwide Fund Advisors first reported a position in Fortress Biotech in Q2 2013 and held it in 10 quarters.
Nationwide Fund Advisors's Fortress Biotech position peaked at $142K in Q3 2013.
62 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.